4.7 Article

Astrocytic TNFα regulates the behavioral response to antidepressants

Journal

BRAIN BEHAVIOR AND IMMUNITY
Volume 44, Issue -, Pages 187-194

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2014.09.012

Keywords

Depression; Cytokine; TNF alpha; Fluoxetine; Desipramine; FST; TST

Funding

  1. Canadian Institute of Health Research
  2. NARSAD Young Investigator award

Ask authors/readers for more resources

Recent studies have suggested that cytokines, and in particular tumor necrosis factor alpha (TNEct), have a role in modulating antidepressant efficacy. To directly test this idea, we compared the response of TNFo-/- mice and astrocyte-specific TNF alpha(-/-) mice to the antidepressants fluoxetine and desipramine. Using standard behavior models for measuring antidepressant efficacy, the forced swim test (EST) and tail suspension test (TST), we determined that TNF alpha(-/-) mice were essentially normal in basal behavior in the FST and TST. However, TINIFcci- mice showed no behavioral response to a standard dose of chronic antidepressant treatment, in sharp contrast to wildtype mice. Similar results were seen with acute antidepressant treatment, but TNF alpha(-/-) mice did respond to a very high-dose acute antidepressant treatment. We also assessed in vitro and in vivo effects of fluoxetine on INFoi expression. GI ia responded to serotonin in vitro and fluoxetine in vivo by upregulating TNFot mRNA. Consistent with this source of TNFoi, mice with an astrocyte-specific deletion of TNFa also did not respond to standard chronic antidepressant treatment. These data suggest that astrocytic INF alpha. is important to the sensitivity of the behavioral response to administration of antidepressants. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis

Paula Berman, Kate Futoran, Gil M. Lewitus, Dzmitry Mukha, Maya Benami, Tomer Shlomi, David Meiri

SCIENTIFIC REPORTS (2018)

Article Nanoscience & Nanotechnology

Full-Spectrum Cannabis Extract Microdepots Support Controlled Release of Multiple Phytocannabinoids for Extended Therapeutic Effect

Almog Uziel, Anat Gelfand, Keren Amsalem, Paula Berman, Gil M. Lewitus, David Meiri, Dan Y. Lewitus

ACS APPLIED MATERIALS & INTERFACES (2020)

Article Neurosciences

Divergent Synaptic Scaling of Miniature EPSCs following Activity Blockade in Dissociated Neuronal Cultures

Amanda L. Hanes, Andrew G. Koesters, Ming-fai Fong, Haider F. Altimimi, David Stellwagen, Peter Wenner, Kathrin L. Engisch

JOURNAL OF NEUROSCIENCE (2020)

Article Neurosciences

Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study

Joshua Aviram, Yelena Vysotski, Paula Berman, Gil M. Lewitus, Elon Eisenberg, David Meiri

BRAIN SCIENCES (2020)

Article Oncology

Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome

Gil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, Gil M. Lewitus, Lanuel Oz-Ari, Ayellet Jehassi, Avivit Peer, Ilit Turgeman, Olga Vernicova, Paula Berman, Mira Wollner, Mor Moskovitz, David Meiri

CANCERS (2020)

Article Chemistry, Medicinal

Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients

Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Anton Uribayev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Mahmud Abo-Amna, Luiza Akria, Dmitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Or Hazan, Gil Bar-Sela, David Meiri

PHARMACEUTICALS (2020)

Article Pharmacology & Pharmacy

Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients

Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Ben Yellin, Paula Berman, Anna Shapira, David Meiri

Summary: During prolonged medical cannabis treatment for chronic non-cancer pain, pain intensities remained stable while analgesic medication consumption decreased and quality of life improved. The consumption rates of high dose THC and alpha-pinene increased during the treatment period.

FRONTIERS IN PHARMACOLOGY (2021)

Article Anesthesiology

Sex differences in medical cannabis-related adverse effects

Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Paula Berman, Anna Shapira, Shiri Procaccia, David Meiri

Summary: Studies have shown that women are more susceptible to adverse effects from conventional drugs. This study aimed to investigate the differences of medical cannabis-related adverse effects between women and men in patients with chronic noncancer pain. The results showed that women reported more medical cannabis-related adverse effects, possibly due to both the inherent sex effect and the consumption of specific phytocannabinoid compositions.
Article Pharmacology & Pharmacy

Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis

Joshua Aviram, Gil M. Lewitus, Dorit Pud, Shiri Procaccia, Paula Berman, Ben Yellin, Yelena Vysotski, Or Hazan, Elon Eisenberg, David Meiri

Summary: This study aimed to identify patterns of phytocannabinoid compositions associated with medical cannabis treatment response and associated adverse effects. Ten clusters with similar analgesic treatment response rates were identified, but significant differences in adverse effects rates were found at short- and long-term. Specific phytocannabinoid compositions were linked to overall adverse effects rates and specific adverse effects rates, highlighting the need for comprehensive profiling of phytocannabinoids to help physicians prescribe safer cannabis for pain relief.

PHARMACOLOGICAL RESEARCH (2021)

Review Pharmacology & Pharmacy

Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug

Shiri Procaccia, Gil Moshe Lewitus, Carni Lipson Feder, Anna Shapira, Paula Berman, David Meiri

Summary: Medical cannabis and its major components THC and CBD are gaining popularity for various medical purposes, but studies regarding their efficacy are inconclusive due to the versatile nature of the cannabis plant and the interplay between its compounds and the endocannabinoid system.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Sustained TNF signaling is required for the synaptic and anxiety-like behavioral response to acute stress

Gina M. Kemp, Haider F. Altimimi, Yoonmi Nho, Renu Heir, Adam Klyczek, David Stellwagen

Summary: Acute stress induces synaptic plasticity and behavioral changes in the brain. The study reveals that TNF is a crucial mediator in the stress response of mice, required for stress-induced synaptic potentiation and increased anxiety-like behavior. The activation of microglia leads to the long-term release of TNF, while sustained TNF signaling in the ventral hippocampus is necessary for maintaining the stress-induced changes.

MOLECULAR PSYCHIATRY (2022)

Article Neurosciences

Early TNF-Dependent Regulation of Excitatory and Inhibitory Synapses on Striatal Direct Pathway Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease

Julien Chambon, Pragya Komal, Gil M. Lewitus, Gina M. Kemp, Simone Valade, Houaria Adaidi, Noura Al Bistami, David Stellwagen

Summary: Huntington's disease (HD) is a neurodegenerative disease caused by a polyglutamine expansion in the huntingtin gene. Neurodegeneration in HD first occurs in the striatum, accompanied by an elevation in inflammatory cytokines. In a mouse model of HD, early changes in synaptic input onto striatal medium spiny neurons were observed, including an increase in excitatory synaptic strength and a decrease in inhibitory synaptic strength, which are both dependent on the pro-inflammatory cytokine tumor necrosis factor alpha (TNF) signaling. These changes may contribute to the development of excitotoxicity during the progress of HD.

JOURNAL OF NEUROSCIENCE (2023)

Article Clinical Neurology

The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients

Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Mahmoud Abu Amna, Anton Ouryvaev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Luiza Akria, Dimitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Gil Bar-Sela, David Meiri

Summary: The use of medical cannabis to treat cancer-related symptoms is increasing. This study prospectively followed up on the effectiveness and safety of medical cannabis treatment in oncology patients. The results showed that most patients experienced significant improvement in symptoms during medical cannabis treatment, with common but non-serious adverse effects.

FRONTIERS IN PAIN RESEARCH (2022)

Article Chemistry, Analytical

Cannabinoidomics - An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolome

Paula Berman, Liron Sulimani, Anat Gelfand, Keren Amsalem, Gil M. Lewitus, David Meiri

TALANTA (2020)

Article Medicine, General & Internal

Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients

Jeffrey Y. Hergenrather, Joshua Aviram, Yelena Vysotski, Salvatore Campisi-Pinto, Gil M. Lewitus, David Meiri

RAMBAM MAIMONIDES MEDICAL JOURNAL (2020)

Letter Immunology

Reply to letter by Dr. Fu and Dr. Chu: Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders

Wan-Ju Cheng, Hong-Mo Shih, Kuan-Pin Su, Po-Ren Hsueh

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Cognitive, behavioral, neuroimaging and inflammatory biomarkers after hospitalization for COVID-19 in Brazil

Felipe Kenji Sudo, Talita P. Pinto, Fernanda G. Q. Barros-Aragao, Ivanei Bramati, Theo F. Marins, Marina Monteiro, Fernanda Meireles, Rejane Soares, Pilar Erthal, Victor Calil, Naima Assuncao, Natalia Oliveira, Joana Bondarovsky, Camila Lima, Beatriz Chagas, Alana Batista, Julia Lins, Thais L. Pinheiro, Felippe Mendonca, Andrea Silveira de Souza, Fernanda C. Rodrigues, Gabriel R. de Freitas, Pedro Kurtz, Paulo Mattos, Erika C. Rodrigues, Fernanda G. De Felice, Fernanda Tovar-Moll

Summary: Post-COVID-19 Condition (PCC) is a multisystemic syndrome that persists for months after SARS-CoV-2 infection, affecting cognitive function and neuropsychiatric features. A study on COVID-19 survivors in Brazil found that these patients experienced significant difficulties in overall cognition, memory, working memory, and inhibitory control, as well as fatigue, anxiety, and depressive symptoms. In addition, elevated levels of inflammatory markers in the blood were associated with brain microstructural damage and cognitive impairments.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Chemogenetic approaches reveal dual functions of microglia in seizures

Aastha Dheer, Dale B. Bosco, Jiaying Zheng, Lingxiao Wang, Shunyi Zhao, Koichiro Haruwaka, Min-Hee Yi, Abhijeet Barath, Dai-Shi Tian, Long-Jun Wu

Summary: Microglial activation plays a crucial role in the pathology of epilepsy, with both acute and prolonged activation affecting seizure severity and neuronal loss.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Maternal inflammation during pregnancy is associated with risk of ADHD in children at age 10

Julie B. Rosenberg, Jens Richardt Mollegaard Jepsen, Parisa Mohammadzadeh, Astrid Sevelsted, Rebecca Vinding, Mikkel E. Sorensen, David Horner, Kristina Aagaard, Birgitte Fagerlund, Susanne Brix, Nilofar Folsgaard, Ann -Marie M. Schoos, Jakob Stokholm, Bo Chawes, Christos Pantelis, Soren Dalsgaard, Birte Y. Glenthoj, Niels Bilenberg, Klaus Bonnelykke, Bjorn H. Ebdrup

Summary: Clinical data demonstrates a strong association between prenatal maternal inflammation assessed by hs-CRP and a diagnosis of ADHD by age 10. Maternal inflammation is also associated with ADHD symptom load in the entire cohort.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Voluntary wheel running prevents formation of membrane attack complexes and myelin degradation after peripheral nerve injury

Suzanne M. Green-Fulgham, Michael J. Lacagnina, Kendal F. Willcox, Jiahe Li, Michael E. Harland, Adriano Polican Ciena, Igor R. Correia Rocha, Jayson B. Ball, Renee A. Dreher, Younus A. Zuberi, Joseph M. Dragavon, Marucia Chacur, Steven F. Maier, Linda R. Watkins, Peter M. Grace

Summary: Regular aerobic activity, specifically voluntary wheel running, can reduce the risk of chronic pain by inhibiting MAC and preserving myelin integrity at the site of peripheral nerve injury.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Neuronanomedicine for Alzheimer's and Parkinson's disease: Current progress and a guide to improve clinical translation

India Boyton, Stella M. Valenzuela, Lyndsey E. Collins-Praino, Andrew Care

Summary: Neuronanomedicine is a multidisciplinary field that aims to develop innovative nanotechnologies for the treatment of neurodegenerative disorders. Nanoparticles are an important component of neuronanomedicine, as they can improve drug properties and enhance safety and delivery across the blood-brain barrier. However, a major challenge for neuronanomedicine translation is the poor understanding of bio-nano interactions, partly due to inconsistent reporting in published works. This review provides specific recommendations to guide researchers in harnessing the unique properties of nanoparticles for breakthrough treatments of Alzheimer's and Parkinson's disease.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Mind versus body: Perceived stress and biological stress are independently related to cognitive decline

Celine De Looze, Cathal McCrory, Aisling O'Halloran, Silvia Polidoro, Rose Anne Kenny, Joanne Feeney

Summary: Our study found that subjective measures of stress and biological metrics may be independently associated with cognitive function over time in older adults, hinting at potential different underlying mechanisms.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Choroid plexus volume is increased in mood disorders and associates with circulating inflammatory cytokines

Beatrice Bravi, Elisa Maria Teresa Melloni, Marco Paolini, Mariagrazia Palladini, Federico Calesella, Laura Servidio, Elena Agnoletto, Sara Poletti, Cristina Lorenzi, Cristina Colombo, Francesco Benedetti

Summary: Depressed patients show changes in immune-inflammatory markers in their blood and cerebrospinal fluid. The Choroid Plexus, located at the base of the brain ventricles, plays a key role in regulating the exchange of substances between the brain and immune cells. Patients with bipolar disorder or major depressive disorder have larger Choroid Plexus volumes compared to healthy controls. Age and levels of circulating cytokines are associated with Choroid Plexus volumes in the clinical groups.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Probiotic Clostridium butyricum ameliorates cognitive impairment in obesity via the microbiota-gut-brain axis

Mingxuan Zheng, Huaiyu Ye, Xiaoying Yang, Lijun Shen, Xuemei Dang, Xiaoli Liu, Yuying Gong, Qingyuan Wu, Li Wang, Xing Ge, Xiaoli Fang, Benchi Hou, Peng Zhang, Renxian Tang, Kuiyang Zheng, Xu-Feng Huang, Yinghua Yu

Summary: Obesity is linked to cognitive dysfunction and neurodegenerative disease. The connection between the gut microbiota and the brain is altered in obesity. The probiotic Clostridium butyricum can improve cognitive impairment caused by obesity and prevent gut microbiota dysbiosis and inflammation.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Stem-cell derived neurosphere assay highlights the effects of viral infection on human cortical development

Edward Drydale, Phalguni Rath, Katie Holden, Gregory Holt, Laurissa Havins, Thomas Johnson, James Bancroft, Lahiru Handunnetthi

Summary: This study created a novel three-dimensional neurosphere assay using induced pluripotent stem cell differentiation and live cell imaging techniques to investigate the effect of a simulated viral infection on cortical development. The findings demonstrated that the infection led to reduced radial glial growth and neural migration.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

An integral blood-brain barrier in adulthood relies on microglia-derived PDGFB

Yuancheng Weng, Ningting Chen, Rui Zhang, Jian He, Xukai Ding, Guo Cheng, Qianqian Bi, Ying-mei Lu, Xiao Z. Shen, Shu Wan, Peng Shi

Summary: This study reveals that microglia is the primary cellular source of PDGFB in adults, and microglial PDGFB is crucial for maintaining BBB integrity in adult mice.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Gonadal hormones impart male-biased behavioral vulnerabilities to immune activation via microglial mitochondrial function

Evan A. Bordt, Haley A. Moya, Young Chan Jo, Caitlin T. Ravichandran, Izabella M. Bankowski, Alexis M. Ceasrine, Christopher J. Mcdougle, William A. Carlezon Jr, Staci D. Bilbo

Summary: There is a strong male bias in many neurodevelopmental disorders such as autism spectrum disorder, but the mechanisms behind this bias are unknown. Infection during the perinatal period increases the risk of neurodevelopmental disorders. Using a mouse model, researchers found that early-life immune activation only induced deficits in social behaviors in male mice. These behavioral changes were associated with alterations in microglial immune signaling, mitochondrial morphology, gene expression, and function specifically in microglia, the brain's innate immune cells. Furthermore, the vulnerability to early-life immune activation and its effects on behavior and microglial mitochondria were programmed by the male-typical perinatal gonadal hormone surge. These findings highlight the role of microglia-specific mechanisms shaped by early developmental events in regulating male social behavior throughout lifespan.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Interleukin-15 alters hippocampal synaptic transmission and impairs episodic memory formation in mice

Maria Amalia Di Castro, Stefano Garofalo, Alessandro Mormino, Laura Carbonari, Erika Di Pietro, Eleonora De Felice, Myriam Catalano, Laura Maggi, Cristina Limatola

Summary: Cytokines, such as interleukin-15 (IL-15), play important roles in modulating the central nervous system (CNS). In this study, the authors found that exposure to IL-15 enhances GABA release and reduces glutamatergic currents in hippocampal slices. Chronic treatment with IL-15 has negative effects on memory formation. Serotonin is involved in mediating these effects, as a selective 5-HT3A receptor antagonist prevents the effects on inhibitory neurotransmission and improves performance in a memory test.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Comprehensive immunoprofiling of neurodevelopmental disorders suggests three distinct classes based on increased neurogenesis, Th-1 polarization or IL-1 signaling

Nikhitha Sreenivas, Michael Maes, Hansashree Padmanabha, Apoorva Dharmendra, Priyanka Chakkera, Saptamita Paul Choudhury, Fazal Abdul, Thrinath Mullapudi, Vykuntaraju K. Gowda, Michael Berk, John Vijay Sagar Kommu, Monojit Debnath

Summary: Neurodevelopmental disorders (NDDs) are a spectrum of conditions with both common and differing characteristics in terms of phenome, symptomatome, neuropathology, risk factors and underlying mechanisms. This study investigates the possibility of a shared immune etiology among three early-onset NDDs, namely Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD) and Intellectual Disability Disorder (IDD).

BRAIN BEHAVIOR AND IMMUNITY (2024)